| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.21 | 0.0001 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0005 |